State Administration for Market Regulation: 22 monopoly cases settled last year, with fines totaling more than 6 billion yuan.

According to the State Administration for Market Regulation, by the year 2025, the market regulation authorities have concluded a total of 22 monopoly cases with a total fine of 653 million yuan. Focusing on key drugs such as scarce drugs, emergency rescue drugs, and commonly used drugs, the market regulation authorities are vigorously promoting the investigation and handling of major monopoly cases in the pharmaceutical field. The monopoly case of the injection of Artemether was investigated and fined 223 million yuan; the monopoly agreement case of dexamethasone sodium phosphate raw materials was investigated and fined 362 million yuan, with the organizer being fined the maximum penalty of 5 million yuan, and the related enterprises being fined up to 8% of their sales from the previous year, leading to a reduction in drug prices by nearly 94%.